Oncology

Your Article Summary

See Latest Articles

Implications of CD34+ cell dose on clinical and haematological outcome of allo-SCT for acquired aplastic anaemia
Bone Marrow Transplantation, 10/15/09

Islam MS et al. – The precise effects of CD34+ cell dose on the outcome of allogeneic transplantation for aplastic anaemia (AA) are not known. Previous studies have used the total mononuclear cell count to quantify stem cell dose. The findings are different to the published studies on the relevance of CD34+ cell dose in allogeneic transplantation for haematological cancers.

Today in Anemia/Polycythemia...keeping you current

Receive free subspecialty "5-minute updates" via email

Update on the use of deferasirox in the management of iron overload
Therapeutics and Clinical Risk Management, 11/05/09

Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia
European Journal of Haematology, 11/04/09

Effect of Epoetin Alfa on Survival and Cancer Treatment-Related Anemia and Fatigue in Patients Receiving Radical Radiotherapy With Curative Intent for Head and Neck Cancer
Journal of Clinical Oncology, 11/09/09

See All of Anemia/Polycythemia

Today in BMT/SCT...keeping you current

Receive free subspecialty "5-minute updates" via email

Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD
Bone Marrow Transplantation, 11/05/09

Management of relapse after allo-SCT for AML and the role of second transplantation
Bone Marrow Transplantation, 10/29/09

Allogeneic hematopoietic stem cell transplantation (alloSCT) for chronic myeloid leukemia in the imatinib era; Evaluation of its impact within a subgroup of the randomized German CML Study IV
Blood, 11/20/09

See All of BMT/SCT